United States · FDA National Drug Code directory
semaglutide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 61434-068_3c676f9f-84a1-f136-e063-6394a90a9770
- Product NDC
- 61434-068
- Form
- INJECTION, SOLUTION
- Composition / generic term
- semaglutide
- Labeler
- Catalent Indiana, LLC
- Marketing category
- DRUG FOR FURTHER PROCESSING
- Marketing start / end (source format)
- 20240722
- Source listing expiry
- 20261231
Source-listed ingredients
- SEMAGLUTIDE — 2.4 mg/.75mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1440 SYRINGE, PLASTIC in 1 CASE (61434-068-00) / .75 mL in 1 SYRINGE, PLASTIC · 61434-068-00
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →